September 1, 2016
View Archives Issues
The checkpoint inhibitor nivolumab failed a Phase III trial as monotherapy in patients with previously untreated non-small cell lung cancer.
New recommendations for clinicians treating heart failure patients include comprehensive medication reconciliation, evaluating risks and benefits of every medication, and discontinuing medications when possible.
Total knee replacement is the surgical procedure most commonly associated with chronic opioid use in opioid-naïve patients.
In this section: FDA approves generic influenza treatment; major pharma loses statin battle; FDA gives thumbs up to agonist to treat type 2 diabetes; agency green lights dry eye disease solution; and approves over-the-counter acne treatment.